Cited by 198RNA and protein synthesis mechanismsVirus-based gene therapy researchRNA Research and Splicing

Adenovirus tripartite leader sequence enhances translation of mRNAs late after infection

Open access
Logan, J, Shenk, T·1984·Proceedings of the National Academy of Sciences

Abstract

A series of adenovirus type 5 variants was constructed to probe the function of the tripartite leader sequence, a 200-nucleotide, 5' noncoding sequence carried on the majority of late viral mRNAs. Recombinant plasmids were constructed that carried the major late transcriptional control region followed by portions of the tripartite leader sequence fused to the E1A coding region. These modified E1A genes were then rebuilt into intact viral chromosomes, replacing the corresponding wild-type region. The leader segments had no effect on the translation of E1A mRNAs early after infection, but the tripartite leader significantly enhanced (5-fold) the efficiency with which the mRNAs were translated late after infection.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.81.12.3655

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • TPL is a nucleotide sequence in the 5′UTR of adenovirus late mRNAs and has previously been thought to initiate translation of late adenoviral mRNAs in a cap-independent manner.

    “TPL is a nucleotide sequence in the 5′UTR of adenovirus late mRNAs and has previously been thought to initiate translation of late adenoviral mRNAs in a cap-independent manner [15,36].”

    From Untranslated Region Sequences and the Efficacy of mRNA Vaccines against Tuberculosis (2024) · cites this paper as [36]

    The paper’s introductory passage identifies the tripartite leader as a 5′ nontranslated sequence shared by most late adenoviral mRNAs. The Discussion says it likely plays a role in translation initiation, but does not say that initiation is cap-independent; that mechanism is unsupported by this source. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • TPL contains an internal ribosome entry site enabling it to recruit a ribosome independently of interactions with the mRNA 5′ 7-methyl G cap.

    “TPL contains an internal ribosome entry site enabling it to recruit a ribosome independently of interactions with the mRNA 5′ 7-methyl G cap.”

    From Untranslated Region Sequences and the Efficacy of mRNA Vaccines against Tuberculosis (2024) · cites this paper as [36]

    The Results report that the tripartite leader enhances mRNA translation late after infection. The Discussion says it may act during translation initiation, but explicitly leaves its mechanism unclear; it does not establish an internal ribosome entry site or recruitment independent of the 5′ cap. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • TPL contains an IRES that allows it to recruit a ribosome independently of interactions with the 5′ 7-methyl G cap of mRNA.

    “This research [43,44] indicates that TPL contains an IRES due to which TPL is capable of recruiting a ribosome, independently of interactions with the 5′ 7-methyl G cap of mRNA.”

    From Effects of Combinations of Untranslated-Region Sequences on Translation of mRNA (2023) · cites this paper as [43]

    The Results report that the tripartite leader enhances translation late after infection, and the Discussion suggests it may act during initiation. But the Discussion says its point of action is unclear; our copy does not establish that it contains an IRES or recruits ribosomes independently of the 5′ cap (page numbers unavailable). (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • The adenovirus tripartite leader (TPL) functions as an enhancer for translation of viral late-gene mRNAs and is thought to initiate translation of late adenoviral mRNAs in a cap-independent manner.

    “The tripartite leader (TPL) of the adenovirus is known to function as an enhancer for translation of viral late-gene mRNAs and is thought to have an ability to initiate translation of late adenoviral mRNAs in a cap-independent manner [43,44].”

    From Effects of Combinations of Untranslated-Region Sequences on Translation of mRNA (2023) · cites this paper as [43]

    The Discussion (page not provided) reports that a nearly intact tripartite leader increased translation efficiency about fivefold late after adenovirus infection, supporting its role as a translational enhancer. The paper does not say that the leader initiates translation in a cap-independent manner; its discussion of the mechanism remains speculative. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • In prior studies, the 5′UTR sequence of TPL consisted of 245 nucleotides and had a complex secondary structure.

    “The 5′UTR sequence of TPL consisted of 245 nucleotides in those studies and had a complex secondary structure.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 2

  1. [1]Berget, S. M., Moore, C. & Sharp, P. A. (1977) Proc. Natl. Acad. Sci. USA 74, 3171–3175.
  2. [28]Scott, M. P. & Pardue, M. L. (1981) Proc. Natl. Acad. Sci. USA 78, 3353–3357.

Cited by

Sorted by citations

Authors
Logan, J., & Shenk, T.
Venue
Proceedings of the National Academy of Sciences
Published
1984-06
Volume
81
Issue
12
Pages
3655-3659
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2003113791
Cited by
198
References
0
Citations by year
2026: 1 · 2024: 2 · 2023: 4 · 2022: 1 · 2019: 2 · 2018: 2 · 2017: 4 · 2016: 1 · 2015: 1 · 2013: 2
FWCI
6.33
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
Keywords
adenovirus type 5, E1A gene, viral gene expression
MeSH terms
Adenoviruses, Human, Base Sequence, Gene Expression Regulation, Mutation, RNA, Messenger, RNA, Viral, Protein Biosynthesis, Virus Replication

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review